interferon
ifn
induc
transmembran
protein
kda
protein
restrict
cellular
infect
influenza
viru
activ
strain
influenza
viru
test
date
regardless
serotyp
speci
origin
similarli
inhibit
mani
medic
import
virus
hiv
sar
coronaviru
ebola
viru
confirm
import
vivo
knockout
mice
succumb
subleth
dose
influenza
viru
likewis
known
protein
genet
polymorph
present
signific
percentag
human
popul
associ
sever
influenza
viru
infect
cell
local
endosom
lysosom
trap
endocytos
viru
particl
within
degrad
compart
imped
format
viru
fusion
pore
yet
even
potent
mechan
limit
infect
influenza
viru
remain
signific
health
concern
may
explain
fact
present
low
level
within
cell
steadi
state
induc
ifn
infect
alreadi
establish
inabl
upregul
level
independ
infect
ifn
challeng
prevent
field
har
activ
infect
prevent
previous
show
ubiquitin
increas
rate
turnov
within
cell
nonubiquitin
lysinetoalanin
mutant
possess
enhanc
antivir
activ
longer
halflif
compar
wt
find
indic
inhibit
ubiquitin
could
augment
activ
andor
level
endogen
thu
offer
strategi
exploit
therapeut
prophylact
viral
infect
identif
ubiquitin
ligas
capabl
modifi
among
annot
ligas
human
genom
import
step
toward
valid
antivir
strategi
work
studi
tyrosin
phosphoryl
discov
phosphoryl
tyrosin
inhibit
ubiquitin
led
us
posit
phosphoryl
may
block
ubiquitin
ligas
recognit
signal
inde
part
highli
conserv
ppxi
motif
p
prolin
x
amino
acid
tyrosin
fig
ppxi
motif
commonli
recogn
ww
character
two
tryptophan
residu
space
approxim
amino
acid
apart
domain
ubiquitin
ligas
nine
famili
member
chose
focu
first
prototyp
member
famili
sever
reason
ubiquit
express
pattern
sever
member
tissuespecif
biogpsorg
like
mani
known
substrat
membran
protein
associ
endosom
lysosom
pathway
spalmitoyl
suggest
may
local
similar
membran
subdomain
report
inhibit
ifninduc
protein
thu
provid
intrigu
model
wherebi
ifn
might
induc
express
also
inhibit
ubiquitin
herein
provid
result
demonstr
abil
ubiquitin
identifi
uniqu
role
decreas
steadi
state
abund
lead
increas
cellular
suscept
influenza
viru
infect
explor
possibl
ubiquitin
first
examin
whether
proxim
one
anoth
within
cell
stimul
mous
embryon
fibroblast
mef
induc
abund
express
perform
immunofluoresc
microscopi
imag
endogen
detect
coloc
two
protein
fig
coloc
protein
endogen
lysosom
marker
indic
may
interact
lysosom
fig
next
examin
effect
overexpress
hatag
human
ubiquitin
observ
signific
increas
myctag
human
ubiquitin
express
compar
transfect
control
fig
contrari
increas
ubiquitin
seen
upon
overexpress
hatag
human
cblb
anoth
ubiquitin
ligas
report
interact
associ
regul
immun
respons
fig
addit
examin
effect
overexpress
flagtag
human
ubiquitin
comparison
flagtag
human
member
ubiquitin
ligas
caus
increas
ubiquitin
unabl
robustli
modifi
fig
result
demonstr
possess
degre
specif
lack
cblb
member
previous
mention
ubiquitin
ligas
possess
two
four
characterist
ww
domain
interact
prolinerich
motif
includ
ppxi
motif
substrat
protein
four
ww
domain
contain
highli
conserv
ppxi
motif
within
nterminu
fig
test
whether
domain
requir
ubiquitin
gener
mutant
residu
ppxi
motif
mutat
alanin
design
util
mutant
four
ww
domain
delet
design
upon
cooverexpress
ubiquitin
increas
expect
mutant
unabl
increas
ubiquitin
fig
fact
partial
decreas
steadi
state
ubiquitin
perhap
indic
domin
neg
effect
fig
moreov
mutant
show
less
ubiquitin
wt
unaffect
overexpress
fig
ppxi
motif
share
tyrosin
overlap
motif
known
involv
traffick
plasma
membran
endosom
thu
order
certain
result
observ
mutant
interfer
motif
test
addit
ppxi
mutant
two
prolin
mutat
alanin
tyrosin
mutat
alanin
upon
cooverexpress
ubiquitin
mutant
minim
increas
compar
robust
increas
ubiquitin
wt
fig
interestingli
truncat
form
miss
first
amino
acid
includ
ppxi
motif
preval
certain
human
popul
variant
associ
sever
influenza
viru
infect
rapid
progress
hivrel
diseas
construct
lack
first
amino
acid
expect
larg
unaffect
term
ubiquitin
overexpress
fig
identifi
potenti
import
differ
truncat
fulllength
protein
next
sinc
shown
physic
interact
ppxi
motif
substrat
protein
examin
whether
coimmunoprecipit
one
anoth
found
inde
coimmunoprecipit
one
anoth
fig
suggest
physic
interact
importantli
interact
greatli
diminish
mutant
fig
sum
result
indic
ppxi
motif
requir
strong
interact
ubiquitin
determin
whether
nonenzymat
activ
might
mediat
effect
ubiquitin
test
catalyt
inact
point
mutant
found
mutant
unabl
increas
ubiquitin
establish
catalyt
activ
inde
requir
abil
increas
ubiquitin
fig
sinc
murin
also
possess
ppxi
motif
fig
test
abil
affect
modif
like
observ
increas
ubiquitin
cooverexpress
observ
effect
catalyt
mutant
fig
suggest
possibl
evolutionari
conserv
modif
mice
human
data
implic
ubiquitin
ligas
capabl
enzymat
modifi
mous
human
overexpress
experi
suggest
directli
ubiquitin
fig
effect
could
indirect
therefor
test
abil
purifi
ubiquitin
immunoprecipit
vitro
order
confirm
directli
modifi
incub
purifi
enzymat
cofactor
ubiquitin
reimmunoprecipit
subject
antiubiquitin
western
blot
result
show
capabl
robustli
ubiquitin
vitro
fig
addit
employ
ubiquitin
mutant
could
ad
via
lysin
lysin
linkag
order
examin
whether
preferenti
util
one
polyubiquitin
linkag
modifi
linkag
could
ad
observ
prefer
linkag
long
polyubiquitin
chain
tradit
associ
protein
degrad
fig
result
consist
past
result
use
linkagespecif
antiubiquitin
antibodi
demonstr
ubiquitin
linkag
could
detect
linkag
preval
data
also
consist
previou
result
indic
ubiquitin
promot
turnov
order
examin
effect
endogen
examin
wt
knockout
ko
mous
embryon
fibroblast
mef
also
util
ko
mef
reconstitut
via
retrovir
transduct
remark
western
blot
lysat
ko
cell
show
increas
steadi
state
level
compar
wt
cell
reconstitut
decreas
wt
level
fig
examin
requir
ubiquitin
immunoprecipit
larg
quantiti
lysat
wt
ko
cell
expect
immunoprecipit
reagent
would
satur
thu
provid
us
compar
amount
examin
ubiquitin
inde
ko
cell
ubiquitin
much
less
wt
cell
fig
result
demonstr
requir
proper
steadi
state
ubiquitin
absenc
result
cellular
accumul
unmodifi
given
increas
baselin
level
predict
ko
cell
would
resist
influenza
viru
infect
observ
ko
mef
fact
significantli
less
suscept
infect
influenza
viru
iav
subtyp
strain
respect
compar
wt
control
cell
fig
decreas
suscept
ko
cell
return
wt
level
infect
upon
reconstitut
fig
also
verifi
enhanc
resist
ko
cell
influenza
viru
infect
includ
resist
recent
circul
strain
ko
cell
significantli
less
suscept
wt
cell
infect
influenza
b
viru
ibv
iav
strain
isol
fig
also
examin
retroviru
pseudotyp
vesicular
stomat
viru
vsv
g
protein
also
report
inhibit
expect
percent
ko
cell
infect
vsv
gpseudotyp
viru
significantli
less
wt
cell
fig
sendai
viru
sev
parainfluenza
viru
primarili
fuse
cell
surfac
thu
minim
affect
also
test
unlik
iav
ibv
vsv
gpseudotyp
retroviru
sev
appreci
affect
ko
fig
thu
pattern
viru
restrict
observ
consist
protect
ko
cell
confirm
increas
resist
ko
cell
influenza
viru
infect
due
increas
level
basal
knock
wt
ko
cell
hour
prior
infect
knockdown
verifi
western
blot
cell
lysat
prepar
time
infect
fig
importantli
knockdown
wt
ko
mef
result
increas
influenza
viru
suscept
larg
elimin
resist
ko
cell
infect
fig
overal
experi
demonstr
promot
cellular
suscept
influenza
viru
infect
decreas
level
extend
result
relev
human
lung
cell
util
human
alveolar
epitheli
cell
line
studi
role
regul
steadi
state
level
knockdown
sirna
cell
led
signific
increas
endogen
compar
nontarget
control
sirna
fig
expect
knockdown
led
significantli
greater
resist
iav
infect
fig
importantli
found
relationship
knockdown
increas
level
preserv
two
addit
human
lung
cell
line
fig
taken
togeth
experi
present
fig
data
confirm
evolutionari
conserv
mice
human
regul
cellular
level
work
also
identifi
novel
target
human
cell
improv
resist
influenza
viru
infect
independ
ifn
adapt
immun
degrad
pathway
involv
turnov
steadi
state
previous
investig
sinc
known
associ
endosom
lysosom
system
target
sever
substrat
lysosom
degrad
result
identifi
primari
ubiquitin
ligas
would
suggest
degrad
lysosom
test
hypothesi
util
chloroquin
bafilomycin
inhibit
endosom
lysosom
acidif
thu
activ
phdepend
lysosom
proteas
observ
treatment
lung
cell
two
inhibitor
caus
accumul
fig
similarli
treatment
leupeptin
inhibitor
specif
lysosom
proteas
result
similar
increas
level
fig
contrast
treatment
cell
proteasom
inhibitor
consist
caus
modest
decreas
level
perhap
due
upregul
lysosom
degrad
pathway
proteasom
activ
inhibit
overal
experi
demonstr
consist
coloc
lysosom
fig
ubiquitin
fig
turn
lysosom
degrad
pathway
previou
work
establish
ubiquitin
promot
turnov
thu
identif
ubiquitin
ligas
would
provid
potenti
target
increas
abund
resist
viru
infect
previou
work
studi
regul
endocytosi
phosphoryl
made
serendipit
discoveri
amino
acid
within
involv
regul
ubiquitin
led
us
identifi
involv
ppxi
motif
ubiquitin
fig
knockdown
knockout
human
mous
cell
respect
result
substanti
greater
level
steadyst
fig
accumul
unmodifi
consist
observ
decreas
ubiquitin
ko
cell
fig
addit
intrigu
aspect
find
steadi
state
level
regul
previous
describ
role
ifn
effector
inhibit
ubiquitinlik
protein
specif
bind
block
product
interact
ligas
complex
import
pathway
highlight
two
independ
studi
demonstr
block
monoubiquitin
matrix
protein
ebola
viru
therebi
inhibit
bud
ebola
viruslik
particl
importantli
sever
studi
implic
critic
antivir
effector
iav
ibv
two
studi
demonstr
conjug
onto
iav
protein
ligas
found
isgyl
iav
antagon
viru
replic
interestingli
ibv
specif
block
human
conjug
prevent
interact
activ
enzym
effect
counteract
antivir
effect
posit
high
level
attain
ifn
stimul
result
gene
induct
well
increas
protein
stabil
result
inhibit
current
investig
excit
potenti
synergist
link
work
demonstr
requir
proper
basal
ubiquitin
fig
howev
result
would
also
suggest
addit
ubiquitin
ligas
also
abl
modifi
particularli
present
high
level
support
detect
partial
ubiquitin
variou
mutant
fig
detect
modest
ubiquitin
ko
cell
fig
ident
secondari
ubiquitin
ligas
still
unknown
particular
interest
ubiquitin
ligas
capabl
modifi
truncat
splice
variant
human
significantli
ubiquitin
fig
identifi
ubiquitin
ligas
modifi
diseaseassoci
variant
may
implic
crucial
differ
stabil
degrad
pathway
potenti
underli
defect
possess
protein
nonetheless
data
clearli
implic
primari
ubiquitin
ligas
demonstr
essenti
maintain
low
steadi
state
level
current
work
contrast
prior
studi
conclud
ppxi
motif
involv
regul
level
antivir
activ
overexpress
howev
previou
work
directli
assess
ubiquitin
upon
mutat
ppxi
motif
addit
experi
studi
ubiquitin
prior
work
suggest
examin
overexpress
construct
ubiquitin
subtl
effect
total
protein
level
detect
western
blot
despit
signific
effect
thu
overexpress
like
mask
effect
mutat
ppxi
motif
paramet
previous
test
studi
uncov
novel
mechan
indirectli
promot
cellular
entri
influenza
viru
decreas
level
fig
although
work
first
kind
identifi
neg
regul
level
well
describ
necessari
replic
sever
import
rna
virus
exampl
interact
prolinerich
motif
viral
late
bud
domain
ebola
viru
rabi
viru
hiv
monoubiquitin
domain
promot
effici
bud
viral
egress
necessari
product
viral
spread
howev
remain
determin
whether
inhibit
serv
effect
vivo
antivir
strategi
particularli
sinc
development
essenti
molecul
demonstr
embryon
lethal
ko
mice
likewis
implic
regul
insulinlik
growth
factor
signal
tcellmedi
immun
tumor
suppress
hand
neuron
skelet
musclespecif
ko
mice
viabl
natur
inhibit
viru
infect
perhap
suggest
shortterm
inhibit
occur
without
advers
effect
addit
experiment
need
answer
vital
question
aid
develop
select
inhibitor
area
activ
investig
overal
studi
identifi
inhibit
novel
strategi
prevent
infect
influenza
viru
virus
increas
accumul
antivir
restrict
factor
cell
line
use
studi
mef
cultur
dmem
supplement
gl
dglucos
lglutamin
mgl
sodium
pyruv
fetal
bovin
serum
thermo
scientif
humidifi
incub
cell
purchas
atcc
cell
obtain
atcc
provid
us
dr
gustavo
leon
ohio
state
univers
wt
ko
mef
use
studi
gener
dr
hiroshi
kawab
max
planck
institut
kindli
provid
us
dr
matthew
pratt
univers
southern
california
also
gener
retrovir
reconstitut
control
cell
line
western
blot
cell
plate
confluenc
plate
h
prior
transfect
plasmid
use
lipofectamin
invitrogen
microscopi
mef
plate
confluenc
glass
coverslip
plate
h
prior
overnight
treatment
bei
resourc
construct
express
pcmvha
pcmvmyc
vector
clontech
describ
previous
mutant
made
use
quikchang
multi
sitedirect
mutagenesi
kit
stratagen
plasmid
express
obtain
addgen
plasmid
deposit
dr
joan
memori
sloan
ketter
cancer
center
plasmid
express
hacblb
kindli
provid
dr
jian
zhang
ohio
state
univers
obtain
addgen
plasmid
desposit
jeff
wrana
univers
toronto
knockdown
mef
perform
use
silenc
select
sirna
ambion
catalog
neg
control
ambion
catalog
human
knockdown
nci
nci
cell
perform
use
dharmacon
ontargetplu
smartpool
human
ge
healthcar
catalog
dharmacon
ontargetplu
control
pool
nontarget
control
ge
healthcar
catalog
sirna
transfect
cell
use
lipofectamin
rnaimax
transfect
reagent
invitrogen
transfect
sirna
perform
h
knockdown
h
knockdown
western
blot
cell
lyse
brij
buffer
mm
triethanolamin
mm
nacl
sigma
ph
contain
edtafre
proteas
inhibitor
mixtur
roch
sigma
immunoprecipit
perform
use
ezview
red
anticmyc
antiha
affin
gel
sigma
protein
g
plu
agaros
suspens
calbiochem
conjunct
chloroquin
bafilomycin
leupeptin
purchas
sigma
coimmunoprecipit
assay
adapt
previous
describ
protocol
cell
cotransfect
overnight
plasmid
express
cell
wash
twice
pb
lyse
ice
triton
lysi
buffer
mm
hepe
ph
mn
nacl
triton
glycerol
mm
mm
egta
leupeptin
aprotinin
pepstatin
mm
pmsf
min
centrifug
x
g
min
cell
lysat
set
asid
sampl
order
evalu
via
western
blot
express
gapdh
load
control
equal
concentr
cell
lysat
immunoprecipit
use
ezview
red
anticmyc
antiflag
affin
gel
sigma
per
sampl
h
gentl
nutat
immunoprecipit
wash
three
time
lysi
buffer
examin
western
blot
antimyc
antiflag
immunoprecipit
western
blot
perform
antimyc
development
studi
hybridoma
bank
univers
iowa
deposit
dr
j
michael
bishop
catalog
antiha
clontech
catalog
proteintech
group
catalog
abcam
catalog
millipor
catalog
antiflag
sigma
catalog
antiactin
abcam
catalog
antigapdh
invitrogen
catalog
antibodi
primari
antibodi
use
dilut
secondari
antibodi
goat
antimous
igg
hrp
conjug
millipor
catalog
goat
antirabbit
igg
hrplink
cell
signal
catalog
goat
antimous
gamma
heavi
chain
specif
southernbiotech
catalog
specif
use
detect
immunoprecipit
protein
ubiquitin
dilut
cell
transfect
overnight
plasmid
express
protein
collect
well
one
plate
immunoprecipit
use
antiha
affin
gel
wash
extens
immunoprecipit
protein
affin
gel
resuspend
pb
retriev
protein
use
reaction
contain
ubiquitin
ubiquitin
mutant
boston
biochem
catalogu
no
ligas
boston
biochem
catalogu
nm
ligas
boston
biochem
catalogu
ubiquitin
conjug
reaction
buffer
contain
atp
boston
biochem
catalogu
presenc
absenc
ng
recombin
human
sigma
catalogu
reaction
allow
proceed
h
stop
boil
min
reaction
dilut
ice
cold
brij
buffer
reimmunoprecipit
use
newli
ad
antiha
affin
gel
prior
western
blot
analysi
cell
fix
min
paraformaldehyd
permeabil
triton
pb
min
block
min
fb
pb
primari
antibodi
fragili
abcam
catalogu
santa
cruz
biotechnolog
catalogu
alexa
fluorlabel
antimous
antirabbit
secondari
antibodi
life
technolog
antirat
dylight
secondari
antibodi
abcam
catalogu
dilut
triton
pb
cell
treat
antibodi
sequenti
min
room
temperatur
wash
five
time
triton
pb
antibodi
treatment
glass
slide
mount
prolong
gold
antifad
reagent
contain
dapi
life
technolog
imag
captur
use
fluoview
confoc
microscop
olympu
influenza
virus
apuerto
reassort
viru
possess
hemagglutinin
neuraminidas
gene
propag
embryon
chicken
egg
purchas
day
egg
charl
river
laboratori
h
describ
previous
provid
us
dr
bruno
moltedo
thoma
moran
mount
sinai
school
medicin
viru
isol
obtain
bei
resourc
sponsor
nihniaid
sev
express
green
fluoresc
protein
sevgfp
gener
dr
dominiqu
garcin
univers
de
genev
provid
us
dr
mark
peepl
nationwid
children
hospit
research
institut
sevgfp
propag
embryon
chicken
egg
h
describ
previous
vsv
gpseudotyp
retroviru
express
green
fluoresc
protein
gener
transfect
viral
vector
plenticmvgfppuro
addgen
plasmid
deposit
dr
eric
campeau
packag
plasmid
provid
dr
li
wu
ohio
state
univers
along
plasmid
express
vsv
g
cell
direct
inhibit
gfp
product
expect
sinc
driven
cmv
immedi
earli
promot
bypass
retrovirusspecif
express
machineri
media
chang
h
posttransfect
media
contain
viru
harvest
h
posttransfect
viruscontain
media
centrifug
x
g
min
filter
filter
frozen
store
use
infect
dose
provid
approxim
infect
wt
mef
mef
infect
iav
strain
sev
ibv
multipl
infect
mef
infect
h
except
case
vsv
gpseudotyp
retroviru
infect
analyz
h
infect
cell
infect
iav
strain
multipl
infect
h
infect
cell
wash
pb
harvest
trypsin
edta
cell
fix
paraformaldehyd
min
permeabil
triton
min
iav
infect
cell
stain
antiinfluenza
nucleoprotein
abcam
catalog
directli
conjug
alexa
fluor
use
antibodi
label
kit
life
technolog
ibv
infect
cell
stain
antiibv
nucleoprotein
thermo
scientif
catalogu
follow
antimous
secondari
antibodi
conjug
directli
alexa
fluor
life
technolog
measur
sev
vsv
gpseudotyp
retroviru
infect
rate
done
detect
virusencod
gfp
antibodi
dilut
triton
pb
cell
stain
min
cell
wash
three
time
triton
pb
antibodi
treatment
pb
use
final
resuspens
cell
flow
cytometr
analysi
use
facscanto
ii
flow
cytomet
bd
bioscienc
result
analyz
use
flowjo
softwar
